|

Levetiracetam 500mg Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1

Indications

  • Down Syndrome (Trisomy 21)1
  • Alzheimer Blood Biomarkers1
  • Alzheimer Dementia (AD)1
  • Alzheimer Disease (AD)1
  • Alzheimer's Disease1

Other1 trial

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.